Genetic variation in Glp1r expression influences the rate of gastric emptying in mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 2, 2008, Pages

  Kumar, K Ganesh ^a   Byerley, Lauri O ^a   Volaufova, Julia ^b   Drucker, Daniel J ^c   Churchill, Gary A ^d   Li, Renhua ^d   York, Barbara ^a   Zuberi, Aamir ^a   Richards, Brenda K Smith ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d JACKSON LABORATORY   (United States)

Author keywords

Glucagon like peptide 1 receptor; Quantitative trait locus

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR;

ALLELIC IMBALANCE; ANIMAL EXPERIMENT; ARTICLE; CONGENIC STRAIN; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH EMPTYING;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; EATING; GASTRIC EMPTYING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOMICS; GLUCAGON-LIKE PEPTIDE 1; MICE; MICE, CONGENIC; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCAGON; VARIATION (GENETICS);

EID: 38949149680     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00640.2007     Document Type: Article

References (61)

1. Ahren B. GLP-1 and extra-islet effects. Horm Metab Res 36: 842-845, 2005.
2. Ayachi SE, Borie F, Magous R, Sasaki K, le Nguyen D, Bali JP, Millat B, Jarrousse C. Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39). Neurogastroenterol Motil 17: 302-309, 2005.
3. Bartness TJ, Rowland NE. Diet selection and metabolic fuels in three models of diabetes mellitus. Physiol Behav 31: 539-545, 1983.
4. Blonde L, Klein EJ, Han J, Zhang B, Mac SM, Poon TH, Taylor KL, Trautmann ME, Kim DD, Kendall DM. Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with Type 2 diabetes. Diabetes Obes Metab 8: 436-447, 2006.
5. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193, 2003.
6. Brubaker PL, Drucker DJ. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels 8: 179-188, 2002.
7. Bullock BP, Heller RS, Habener JF. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137: 2968-7829, 1996.
8. Campos RV, Lee YC, Drucker DJ. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134: 2156-2164, 1994.
9. Chelikani PK, Haver AC, Reidelberger RD. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 288: R1695-R1706, 2005.
10. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971, 1994.
11. Cowles CR, Hirschhorn JN, Altshuler D, Lander ES. Detection of regulatory variation in mouse genes. Nat Genet 32: 432-437, 2002.
12. De Jonghe BC, Hajnal A, Covasa M. Decreased gastric mechanodetection, but preserved gastric emptying, in CCK-1 receptor-deficient OLETF rats. Am J Physiol Gastrointest Liver Physiol 291: G640-G649, 2006.
13. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol 282: G424-G431, 2002.
14. Donahey JC, van Dijk G, Woods SC, Seeley RJ. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats. Brain Res 779: 75-83, 1998.
15. Drucker DJ. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122: 531-544, 2002.
16. Dunphy JL, Taylor RG, Fuller PJ. Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol Cell Endocrinol 141: 179-186, 1998.
17. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101: 515-520, 1998.
18. Flint J, Valdar W, Shifman S, Mott R. Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6: 271-286, 2005.
19. Goke RH, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like-peptide 1-(7-36)-amide receptor of insulin-secreting beta cells. J Biol Chem 268: 19650-19655, 1993.
20. Hunt JN, Stubbs DF. The volume and energy content of meals as determinants of gastric emptying. J Physiol 245: 209-225, 1975.
21. Imeryuz N, Yegan BC, Bozkurt A, Coskun T, Villanueva-Penacarrilo ML, Uluson NB. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol Gastrointest Liver Physiol 273: G920-G927, 1997.
22. 13C-octanoic acid breath test. Diabetes Obes Metab 6: 264-270, 2004.
23. Kanarek RB, Ho L. Patterns of nutrient selection in rats with streptozotocin-induced diabetes. Physiol Behav 32: 639-645, 1984.
24. Kirby RJ, Howles PN, Hui DY. Rate of gastric emptying influences dietary cholesterol absorption efficiency in selected inbred strains of mice. J Lipid Res 45: 89-98, 2004.
25. Kiyasu JY, Bloom B, Chaikoff IL. The portal transport of absorbed fatty acids. J Biol Chem 199: 415-421, 1952.
26. Kumar KG, Poole AC, York B, Volaufova J, Zuberi A, Smith Richards BK. Quantitative trait loci for carbohydrate and total energy intake on mouse chromosome 17: congenic strain confirmation and candidate gene analyses (Glo1, Glp1r). Am J Physiol Regul Integr Comp Physiol 292: R207-R216, 2007.
27. Lathe R. Mice, gene targeting and behavior: more than just genetic background. TINS 19: 183-185, 1996.
28. Lee PD, Ge B, Greenwood CM, Sinnett D, Fortin Y, Brunet S, Fortin A, Takane M, Skamene E, Pastinen T, Hallett M, Hudson TJ, Sladek R. Mapping cis-acting regulatory variation in recombinant congenic strains. Physiol Genomics 25: 294-302, 2006.
29. Li R, Tsaih SW, Shockley K, Stylianou IM, Wergedal J, Paigen B, Churchill GA. Structural model analysis of multiple quantitative traits. PLoS Genet 2: e114, 2006.
30. 13C-octanoic acid breath test. Diab Nutr Metab 17: 43-46, 2004.
31. Meier JJ, Nauck MA. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 21: 91-117, 2005.
32. Nagell CF, Wettergren A, Orskov C, Holst JJ. Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs. Scand J Gastroenterol 41: 667-672, 2006.
33. Naslund E, Gutniak M, Skogar S, Rossner S, Hellstrom PM. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr 68: 525-530, 1998.
34. Naslund E, Bogefors J, Skogar S, Gryback P, Jacobsson H, Holst JJ, Hellstrom PM. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol Regul Integr Comp Physiol 277: R910-R916, 1999.
35. Pastinen T, Hudson TJ. Cis-acting regulatory variation in the human genome. Science 306: 647-650, 2004.
36. Raybould HE, Tache Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol Gastrointest Liver Physiol 255: G242-G246, 1988.
37. Raybould HE, Roberts ME, Dockray GJ. Reflex decreases in intragastric pressure in response to cholecystokinin in rats. Am J Physiol Gastrointest Liver Physiol 253: G165-G170, 1987.
38. Richter CP, Schmidt ECH. Increased fat and decreased carbohydrate appetite of pancreatectomized rats. Endocrinology 28: 179-192, 1941.
39. Scharf MT, Ahima RS. Gut peptides and other regulators in obesity. Semin Liver Dis 24: 335-347, 2004.
40. Schirra J, Nicolaus M, Roggel R, Katschinski M, Storr M, Woerle HJ, Goke B. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut 55: 243-251, 2006.
41. Schmidtler J, Dehne K, Allescher HD, Schusdziarra V, Classen M, Holst JJ, Polack A, Schepp W. Rat parietal cell receptors for GLP-1-(7-36) amide: Northern blot, cross-linking, and radioligand binding. Am J Physiol Gastrointest Liver Physiol 267: G423-G432, 1994.
42. 13C analysis for the detection and quantitation of intestinal malabsorption. J Lab Clin Med 97: 439-448, 1981.
43. 13C-octanoic acid breath test: validation of a new noninvasive method of measuring gastric emptying in rats. Neurogastroenterol Motil 14: 287-293, 2002.
44. Scrocchi LA, Brown TJ, Maclusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2: 1254-1258, 1996.
45. Sen S, Churchill GA. A statistical framework for quantitative trait mapping. Genetics 159: 371-387, 2001.
46. Smith Richards BK, Belton BN, Poole AC, Mancuso JJ, Churchill GA, Li R, Volaufova J, Zuberi A, York B. QTL analysis of self-selected macronutrient diet intake: fat, carbohydrate, and total kilocalories. Physiol Genomics 11: 205-217, 2002.
47. Smith Richards BK, Poole A, Belton B, Li R, Churchill GA, York B. Glucagon-like peptide 1 receptor (Glp1r): Candidate gene for a quantitative trait locus (QTL) controlling food volume in mice. Obesity Res 11: A69, 2003.
48. 13C]-octanoic acid breath test. Clin Exp Pharmacol Physiol 27: 671-675, 2000.
49. Symonds E, Butler R, Omari T. Noninvasive breath tests can detect alterations in gastric emptying in the mouse. Eur J Clin Invest 32: 341-344, 2002.
50. Symonds E, Butler R, Omari T. The effect of the GABAB receptor agonist baclofen on liquid and solid gastric emptying in mice. Eur J Pharmacol 470: 95-97, 2003.
51. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146: 3748-56, 2005.
52. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89: 8641-8645, 1992.
53. Thorens B, Porret A, Buhler L, Deng SP, Morel P, Widmann C. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42: 1678-1682, 1993.
54. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1996.
55. Uttenthal LO, Blazquez E. Characterization of high-affinity receptors for truncated glucagon-like peptide-l in rat gastric glands. FEBS Lett 262: 139-141, 1990.
56. Vazquez P, Roncero I, Blazquez E, Alvarez E. The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation. J Endocrinol 186: 221-231, 2005.
57. Wang H, Elbein SC. Detection of allelic imbalance in gene expression using pyrosequencing. Methods Mol Biol 373: 157-176, 2007.
58. Wang L, Martinez V, Rivier JI, Tache Y. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol 281: R1401-R1410, 2001.
59. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38: 665-673, 1993.
60. Wettergren A, Wojdemann M, Holst JJ. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol Gastrointest Liver Physiol 275: G984-G992, 1998.
61. Wishert JM, Horowitz M, Morris HA, Jones KL, Nauck MA. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1. Peptides 19: 1049-1053, 1998.